Literature DB >> 2559953

Evaluation of a new enzyme-linked immunosorbent assay (ELISA) in the diagnosis of rhinovirus infection.

W al-Nakib1, C J Dearden, D A Tyrrell.   

Abstract

This study describes the evaluation of a newly developed ELISA for the direct detection of rhinovirus antigens in nasal washings. Of 54 volunteers inoculated with 100 TCID50 of human rhinovirus type 2 (HRV-2), 50 (96.6%) and 32 (59%) excreted antigen and virus on at least 1 of 3 days investigated, respectively. Thirty-three (61%) had significant rises in rhinovirus-specific IgA by ELISA. Twelve (22%) developed symptoms of colds. Generally the ELISA detected antigen more frequently in volunteers later in the course of infection and provided evidence of infection in a higher proportion of asymptomatic compared with symptomatic volunteers. On the other hand, virus isolation detected virus more frequently earlier in the course of infection and in a higher proportion of symptomatic compared with asymptomatic volunteers. We conclude that rhinovirus antigen detection by ELISA is a simple, rapid, sensitive, and practical test to diagnose a rhinovirus infection and potentially a viable alternative to virus isolation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559953      PMCID: PMC7166371          DOI: 10.1002/jmv.1890290410

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

Review 1.  The common cold: control?

Authors:  R B Couch
Journal:  J Infect Dis       Date:  1984-08       Impact factor: 5.226

2.  The association of rhinoviruses with lower respiratory tract disease in hospitalized patients.

Authors:  L Krilov; L Pierik; E Keller; K Mahan; D Watson; M Hirsch; V Hamparian; K McIntosh
Journal:  J Med Virol       Date:  1986-08       Impact factor: 2.327

3.  Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837).

Authors:  W al-Nakib; P G Higgins; G I Barrow; D A Tyrrell; K Andries; G Vanden Bussche; N Taylor; P A Janssen
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

4.  Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges.

Authors:  W Al-Nakib; P G Higgins; I Barrow; G Batstone; D A Tyrrell
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

6.  Rapid viral diagnosis of acute respiratory infections: comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions.

Authors:  M Grandien; C A Pettersson; P S Gardner; A Linde; A Stanton
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

7.  Provocation of airflow limitation by viral infection: implication for treatment.

Authors:  I Gregg
Journal:  Eur J Respir Dis Suppl       Date:  1983

8.  Evaluation of an enzyme-linked immunosorbent assay that measures rhinovirus-specific antibodies in human sera and nasal secretions.

Authors:  W S Barclay; K A Callow; M Sergeant; W al-Nakib
Journal:  J Med Virol       Date:  1988-08       Impact factor: 2.327

9.  Direct detection of rhinoviruses by an enzyme-linked immunosorbent assay.

Authors:  C J Dearden; W Al-Nakib
Journal:  J Med Virol       Date:  1987-10       Impact factor: 2.327

10.  Use of synthetic oligonucleotide probes to detect rhinovirus RNA.

Authors:  C B Bruce; W al-Nakib; J W Almond; D A Tyrrell
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

View more
  2 in total

1.  Comparison of monoclonal biotin-avidin enzyme immunoassay and monoclonal time-resolved fluoroimmunoassay in detection of respiratory virus antigens.

Authors:  G Scalia; P E Halonen; F Condorelli; M L Mattila; J C Hierholzer
Journal:  Clin Diagn Virol       Date:  1995-05

Review 2.  Microfluidic-based virus detection methods for respiratory diseases.

Authors:  E Alperay Tarim; Betul Karakuzu; Cemre Oksuz; Oyku Sarigil; Melike Kizilkaya; Mahmoud Khatib A A Al-Ruweidi; Huseyin Cagatay Yalcin; Engin Ozcivici; H Cumhur Tekin
Journal:  Emergent Mater       Date:  2021-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.